Pharmadax Inc (法德生技藥品) yesterday said that it aims to gain approval to market two of its generic drugs — one for high blood pressure and one for schizophrenia — in the US and China by the end of this year.
The US Food and Drug Administration’s (FDA) approval process for the company’s hypertension tablet, Metoprolol Succinate ER — the generic version of Toprol-XL sold by AstraZeneca PLC — has entered the final stage, Pharmadax founder Huang Yi-pin (黃逸斌) told a media briefing in Taipei.
The company last month submitted more documents to the FDA, which is expected to reply within three months, Huang said, adding that Pharmadax is confident of gaining approval in the second half of this year.
The company first applied for approval from the FDA in 2010, Huang said, adding that the long approval process has not reduced the hypertension drug’s business potential, as demand is high, but suppliers are few.
“Americans consume an average of 2.7 billion Metoprolol Succinate ER tablets per year. AstraZeneca’s patent in the US expired more than 10 years ago, but few pharmaceutical companies know how to produce the drug, enabling AstraZeneca and its authorized companies to hold onto more than 40 percent of the market,” Huang said.
Pharmadax aims to win at least a 25 percent of the US market, and plans to expand production capacity at its Chinese plant in Foshan, Guangdong, to supply more than 600 million tablets per year after gaining approval, Huang said.
“Economies of scale matter. If we cannot provide enough for our distributors, they will be reluctant to help us promote the product,” Huang said.
Pharmadax also expects to gain marketing approval in China for its Quetiapine Fumarate ER tablet, the generic version of AstraZeneca’s Seroquel XR tablet, which is used to treat schizophrenia.
The business potential for the psychotropic drug would be good, as there is only one brand of the drug in the Chinese market, Huang said.
Meanwhile, the company plans to develop a new drug to treat dry eye syndrome in cooperation with Boston-based Glia LLC, Pharmadax board director Francis Chung (鍾裕民) said.
Unlike artificial tears, it would be a gel-like compound that people would apply to their foreheads to encourage the cranial nerves to secrete more tears, Chung said.
Pharmadax plans to move its shares from the less-active Emerging Stock Board to the Taipei Exchange by the end of this year, thanks to a recommendation letter the Industrial Development Bureau wrote last month, the company said.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
TRANSFORMATION: Taiwan is now home to the largest Google hardware research and development center outside of the US, thanks to the nation’s economic policies President Tsai Ing-wen (蔡英文) yesterday attended an event marking the opening of Google’s second hardware research and development (R&D) office in Taiwan, which was held at New Taipei City’s Banciao District (板橋). This signals Taiwan’s transformation into the world’s largest Google hardware research and development center outside of the US, validating the nation’s economic policy in the past eight years, she said. The “five plus two” innovative industries policy, “six core strategic industries” initiative and infrastructure projects have grown the national industry and established resilient supply chains that withstood the COVID-19 pandemic, Tsai said. Taiwan has improved investment conditions of the domestic economy
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day